| Safety and Efficacy of Probiotics in Bangladeshi Infants (NCT01899378) | Stanford University | 2013-10-01 |
| Effects of Intranasal Administration of a Single Dose of Oxytocin Using a Novel Device in Healthy Adults (NCT01983514) | OptiNose AS | 2013-10-01 |
| A Pharmacokinetic Study to Evaluate the Effect of MAALOX on Raltegravir (MK-0518) in Human Immunodeficiency Virus (HIV)-Infected Participants (MK-0518-295) (NCT01930045) | Merck Sharp & Dohme LLC | 2013-10-01 |
| A Two-part Study to Assess the Safety and Preliminary Efficacy of Givinostat in Patients With Polycythemia Vera (NCT01901432) | Italfarmaco | 2013-10-01 |
| Low-dose GH Supplementation Increases Clinical Pregnancy Rate (NCT02359695) | Centro de Infertilidad y Reproducción Humana | 2013-10-01 |
| ESI With EUS to Differentiate T3 and T4 ESCC (NCT01930630) | Sun Yat-sen University | 2013-10-01 |
| Single Dose and Multiple Dose Trial to Assess Pharmacokinetics of Obeticholic Acid (OCA) (NCT01933503) | Intercept Pharmaceuticals | 2013-10-01 |
| A Study to Evaluate Safety, Toleration and Time Course of Plasma Concentration of Multiple Oral Doses of PF-06273340 in Healthy Subjects of Two AgeGroups, Aged 18-55 Years (Group 1) and Aged 56-75 Years (Group 2) (NCT01934738) | Pfizer | 2013-10-01 |
| Phase I Safety Study of Dendritic Cell Vaccine to Treat Patients With Hepatocellular Carcinoma (NCT01974661) | Mendus | 2013-10-01 |
| Comparison of the Efficacy and Mechanisms for MBCT and CT for Multiple Sclerosis (MS) Chronic Pain (NCT02012439) | University of Washington | 2013-10-01 |
| Safety Study of AADC Gene Therapy (VY-AADC01) for Parkinson's Disease (NCT01973543) | Neurocrine Biosciences | 2013-10-01 |
| Comparison of Two Formulations of Proellex for Vaginal Administration (NCT01962805) | Repros Therapeutics Inc. | 2013-10-01 |
| A Study of LY2157299 in Healthy Participants (NCT01965808) | Eli Lilly and Company | 2013-10-01 |
| Study Evaluating Absorption, Distribution, Metabolism and Excretion (ADME) of Single Dose [14C] Selumetinib in Volunteers (NCT01931761) | AstraZeneca | 2013-10-01 |
| Study of the Pharmacokinetics and Safety of Carfilzomib in Patients With Advanced Malignancies and Hepatic Impairment (NCT01949545) | Amgen | 2013-10-01 |
| Phase 1b Trial of BGJ398/BYL719 in Solid Tumors (NCT01928459) | Novartis Pharmaceuticals | 2013-10-01 |
| Open Label Treatment With tDCS for Parkinson's and Related Disorders for Improvement of Speech, Gait and Mood (NCT02104401) | Georgetown University | 2013-10-01 |
| Safety and Tolerability of Trametinib in Combination With Docetaxel in Japanese Subjects With Non-small Cell Lung Cancer (NCT01938456) | GlaxoSmithKline | 2013-10-01 |
| An Investigational Study of Hydrocortisone (NCT01960530) | Neurocrine UK Limited | 2013-10-01 |
| A Safety Study of Mirikizumab (LY3074828) (NCT01947933) | Eli Lilly and Company | 2013-10-01 |
| Reactogenicity, Safety and Immunogenicity of a Live Monovalent A/17/CALIFORNIA/66/395 (H2N2) Influenza Vaccine (NCT01982331) | PATH | 2013-10-01 |
| Effects of Head Elevation by a Bed on Sleep-disordered Breathing (NCT01785199) | Mackay Memorial Hospital | 2013-10-01 |
| Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Ascending Oral Doses and Effect of Food on the Bioavailability of BI 1060469 (NCT01971502) | Boehringer Ingelheim | 2013-10-01 |
| L-asparaginase Encapsulated in Red Blood Cells (Eryaspase) for Treatment of Adult Patients With ALL or LBL (NCT01910428) | ERYtech Pharma | 2013-10-01 |
| Pharmacokinetics and Safety Study of LY03003 in Patients With Early-stage Parkinson's Disease (NCT02055274) | Luye Pharma Group Ltd. | 2013-10-01 |
| Trial of Computerized MET for Adolescent Substance Use (NCT01784653) | Boston Children's Hospital | 2013-10-01 |
| CPI-613 in Treating Patients With Relapsed or Refractory Small Cell Lung Cancer (NCT01931787) | Wake Forest University Health Sciences | 2013-10-01 |
| A Pharmacokinetics Study to Investigate the Effect of Ketoconazole on Vemurafenib in Patients With BRAFV600 Mutation-Positive Metastatic Melanoma (NCT01765556) | Hoffmann-La Roche | 2013-10-01 |
| Open Label Pharmacokinetic Study of OZ439 and Piperaquine on Administration of OZ439+TPGS Granules for Oral Suspension Alone or With Either Piperaquine Phosphate Tablets or Granules for Oral Solution in Healthy Volunteers (NCT01958619) | Medicines for Malaria Venture | 2013-10-01 |
| A Prospective, Open Phase I Study to Investigate the Tolerability and Efficacy of ALECSAT to Pancreas Cancer Patients (NCT01984658) | CytoVac A/S | 2013-10-01 |
| Safety and Efficacy of Squaric Acid Dibutyl Ester for the Treatment of Herpes Labialis (NCT01971385) | Massachusetts General Hospital | 2013-10-01 |
| Intrapleural AdV-tk Therapy in Patients With Malignant Pleural Effusion (NCT01997190) | Candel Therapeutics, Inc. | 2013-10-01 |
| A Phase I Study to Assess the Safety, Tolerability and PK of Ceftazidime-Avibactam in Healthy Chinese Subjects (NCT01920399) | Pfizer | 2013-10-01 |
| A Study to Evaluate Safety, Tolerability, Pharmacokinetics and Activity of Oraxol in Subjects With Advanced Malignancies (NCT01967043) | Kinex Pharmaceuticals Inc. | 2013-10-01 |
| Drug-Drug Interaction Study to Evaluate the Effect of Colestilan on the Pharmacokinetics of Single Doses of Candesartan Cilexetil in Healthy Subjects (NCT01976572) | Tanabe Pharma Corporation | 2013-10-01 |
| Study Assessing the Safety, Tolerability, and Pharmacokinetics of SEP-363856 in Male and Female Subjects With Schizophrenia (NCT01994473) | Otsuka Pharmaceutical Development & Commercialization, Inc. | 2013-10-01 |
| A Phase I Study Of Panobinostat/Lenalidomide/Bortezomib/Dex for Relapsed And Relapsed/Refractory Multiple Myeloma (NCT01965353) | Dana-Farber Cancer Institute | 2013-10-01 |
| Metformin's Effect on Glucagon-induced Glucose Production and Protein Metabolism. (NCT01956929) | Mayo Clinic | 2013-10-01 |
| Study to Investigate the Absolute Bioavailability of Oral Sylibin (NCT02633696) | Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal | 2013-10-01 |
| Phase I Study of Ad5-hGCC (Human Guanylyl Cyclase C)-PADRE in Stage I/II Colon Cancer (NCT01972737) | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 2013-10-01 |
| Study, Double Blind, Randomized, Comparing Two Groups to Evaluate the Safety and Efficacy of Autologous Mesenchymal Stem Cells From Adipose Tissue (CMMAd) in the Treatment of the Faecal Incontinence (NCT02292628) | Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud | 2013-10-01 |
| A Phase 1, Open-Label Study to Assess the Single-Dose Pharmacokinetics of Eravacycline in Subjects With Impaired Hepatic Function and Healthy Subjects (NCT02135302) | Tetraphase Pharmaceuticals, Inc | 2013-10-01 |
| Safety Study of Intratumoral Injection of Clostridium Novyi-NT Spores to Treat Patients With Solid Tumors That Have Not Responded to Standard Therapies (NCT01924689) | BioMed Valley Discoveries, Inc | 2013-10-01 |
| Romidepsin, Gemcitabine, Dexamethasone and Cisplatin in the Treatment of Peripheral T-Cell and Diffuse Large B-Cell Lymphoma (NCT01846390) | Canadian Cancer Trials Group | 2013-10-01 |
| Study to Evaluate the Safety and Efficacy of JVS-100 Administered to Adults With Ischemic Heart Failure (NCT01961726) | Juventas Therapeutics, Inc. | 2013-10-01 |
| A Study of Insulin Peglispro and Glargine on Fats in Participants With Type 1 Diabetes (NCT01771250) | Eli Lilly and Company | 2013-10-01 |
| Phase II Study of Buparlisib + Docetaxel in Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) Patients (NCT01911325) | Novartis Pharmaceuticals | 2013-10-01 |
| CD-NP (Cenderitide) Therapy for the Preservation of Left Ventricular Function (NCT02071602) | Mayo Clinic | 2013-10-01 |
| Three-level Injection Paravertebral Block vs General Anesthesia in Mastectomy (NCT02065947) | Ramathibodi Hospital | 2013-10-01 |
| A Study of Baricitinib and Omeprazole in Healthy Participants (NCT01925144) | Eli Lilly and Company | 2013-10-01 |
| Inpatient Evaluation of the MD-Logic Artificial Pancreas System in Patients With Type 1 Diabetes (NCT01501032) | Rabin Medical Center | 2013-10-01 |
| Safety, Tolerability and Pharmacokinetics of Inhaled Laninamivir Octanoate TwinCaps® DPI in Adults With Chronic Asthma (NCT02022761) | Biota Scientific Management Pty Ltd | 2013-10-01 |
| Pharmacokinetic Interaction Study of Dapoxetine 30mg and Mirodenafil 50mg (NCT02485028) | SK Chemicals Co., Ltd. | 2013-10-01 |
| Allogeneic Mesenchymal Stem Cells for the Critical Limb Ischemia Therapy (NCT03239535) | Federal Research Clinical Center of Federal Medical & Biological Agency, Russia | 2013-10-01 |
| Pharmacokinetics, Safety and Tolerability of the Combination of BI 207127 and Faldaprevir in Renal Impaired Patients (NCT01957657) | Boehringer Ingelheim | 2013-10-01 |
| To Assess the Effect of Itraconazole (a CYP3A4 Inhibitor) on the Pharmacokinetics of Olaparib, and the Effect of Olaparib on QT Interval Following Oral Dosing of a Tablet Formulation to Patients With Advanced Solid Tumours (NCT01900028) | AstraZeneca | 2013-10-01 |
| Safety and Bioavailability of IV and SC LBR-101 (NCT01991509) | Teva Branded Pharmaceutical Products R&D, Inc. | 2013-10-01 |
| Depletion of Serum Amyloid P Component to Enhance the Immune Response to DNA Vaccination (NCT02425241) | University College, London | 2013-10-01 |
| Nebulized Hypertonic Saline for Mechanically Ventilated Children (NCT01945944) | University Hospitals Cleveland Medical Center | 2013-10-01 |
| Effect of Hemodialysis on the PK of JTZ-951 in Subjects With End-stage Renal Disease (NCT01978587) | Akros Pharma Inc. | 2013-10-01 |
| Methylene Blue Injection for Nonneoplastic Epithelial Disorders of Vulva (NCT03200808) | Maternal and Child Health Hospital of Hubei Province | 2013-10-01 |
| BP31510 (Ubidecarenone,USP) Nanosuspension for Intravenous Injection to Patients With Solid Tumors (NCT01957735) | BPGbio | 2013-10-01 |
| Pharmacokinetic Evaluation and Tolerability of Dry Powder Tobramycin by a Novel Device in Patients With Non Cystic Fibrosis Bronchiectasis (NCT02035488) | University Medical Center Groningen | 2013-10-01 |
| Safety and Efficacy Study of Vemurafenib and High-dose Interferon Alfa-2b in Melanoma (NCT01943422) | John Kirkwood | 2013-10-01 |
| Bioequivalence Study to Assess Systemic Exposure of FP and SAL FDC From Different DPIs (NCT02215122) | Mylan Pharma UK Ltd. | 2013-10-01 |
| Safety, Tolerability and Pharmacokinetics (PK) of RV1162 in Healthy Subjects and COPD Patients (NCT01970618) | Respivert Ltd | 2013-10-01 |
| Magnesium Treatment of Inflammation in Disorders of Glucose Homeostasis (NCT01980459) | George Washington University | 2013-10-01 |
| Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study of Single Escalating Doses of BI 1034020 Administered Intravenously or Subcutaneously to Male Healthy Volunteers (NCT01958060) | Boehringer Ingelheim | 2013-10-01 |
| Effect of Carbamazepine on Dolutegravir Pharmacokinetics in Healthy Adult Subjects (NCT01967771) | ViiV Healthcare | 2013-10-01 |
| Umbilical Cord Tissue-derived Mesenchymal Stem Cells for Rheumatoid Arthritis (NCT01985464) | Translational Biosciences | 2013-10-01 |
| Study of the Safety and Effectiveness of Collagen Cross-Linking at an Irradiance of 9 mW/cm2 and 18 mW/cm2 (NCT02009709) | Robert Mack, M.D. | 2013-10-01 |
| TD-9855 Mass Balance Study (NCT01924143) | Theravance Biopharma | 2013-10-01 |
| Effects of Propranolol (vs. Placebo) on Information Processing During Presentation of Emotionally Arousing Pictures (NCT02509559) | University Medicine Greifswald | 2013-10-01 |
| Phase 1/2 CTO + Bevacizumab for Recurrent Glioma Post-Bevacizumab Failure (NCT01954030) | Annick Desjardins | 2013-10-01 |
| Folic Acid-Tubulysin Conjugate EC1456 In Patients With Advanced Solid Tumors (NCT01999738) | Endocyte | 2013-10-01 |
| T Cell Transfer With or Without Dendritic Cell Vaccination in Patients With Melanoma (NCT01946373) | Karolinska University Hospital | 2013-10-01 |
| A Study of Evacetrapib in Japanese and Non-Japanese Participants (NCT01958489) | Eli Lilly and Company | 2013-10-01 |
| RNActive® Rabies Vaccine (CV7201) in Healthy Adults (NCT02241135) | CureVac | 2013-10-01 |
| A Study to Evaluate the Effect of Verapamil on the Pharmacokinetics of ASP015K in Healthy Adult Subjects (NCT02111317) | Astellas Pharma Global Development, Inc. | 2013-10-01 |
| A Pharmacokinetic Study in Healthy Participants to Assess the Pharmacokinetics and Safety of a Supratherapeutic Dose of PCI-32765 (Ibrutinib) Capsule and Solution Formulations Administered With Food (NCT01969266) | Janssen Research & Development, LLC | 2013-10-01 |
| Burs Versus Curettes in Root Planing. (NCT02875470) | Ege University | 2013-10-01 |
| High Resolution Manometry for Swallowing (NCT01773330) | University of Florida | 2013-10-01 |
| Traumatic Neuroprotection and Epilepsy Prevention of Valproate Acid (NCT02027987) | Xijing Hospital | 2013-10-01 |
| RENABLATE-II Feasibility Study of Catheter Based Renal Denervation to Treat Resistant Hypertension - 157 (NCT02095691) | Biosense Webster, Inc. | 2013-10-01 |
| A Study of Increasing Strengths, Safety and Efficacy of Two Formulas of LEO 43204 on the Face or the Chest in Patients With Actinic Keratosis (NCT01922050) | LEO Pharma | 2013-10-01 |
| Safety and Efficacy Study of Neratinib and Cetuximab to Treat Patients With Quadruple Wild-Type Metastatic Colorectal Cancer (NCT01960023) | NSABP Foundation Inc | 2013-10-01 |
| Safety and Immunogenicity of Plant-Derived Pfs25 VLP-FhCMB Malaria Transmission Blocking Vaccine in Healthy Adults (NCT02013687) | Fraunhofer, Center for Molecular Biotechnology | 2013-10-01 |
| Daclizumab Japanese PK Study (NCT01929746) | Biogen | 2013-10-01 |
| A Study To Investigate The Drug-Drug Interaction Potential Of Rifampin OnThe Investigational Agent Palbociclib (PD-0332991) (NCT01953731) | Pfizer | 2013-10-01 |
| A Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of Oral PTH (1-34) Formulations in Healthy Subjects (NCT02571140) | Entera Bio Ltd. | 2013-10-01 |
| Feasibility Study of Auditory Brainstem Implant in Young Children (NCT01850225) | House Research Institute | 2013-10-01 |
| A Dose Escalating Study to Determine the Tolerability and PK of a Single Dose of Androxal (NCT01959685) | Repros Therapeutics Inc. | 2013-10-01 |
| The Safety and Immunogenicity of a Potential HIV Vaccine (NCT01966900) | Imperial College London | 2013-10-01 |
| Selumetinib (AZD6244, ARRY-142886) J-BTC Phase 1 Study (NCT01949870) | AstraZeneca | 2013-10-01 |
| Oral Immunotherapy for Wheat Allergy (NCT01980992) | Hugh A Sampson, MD | 2013-10-01 |
| The Effect of a Wearable Cueing Device on Freezing of Gait in Parkinson's Disease (NCT02356536) | The University of Queensland | 2013-10-01 |
| A Safety and Efficacy Assessment of Resolvine for Treatment of Vitreomacular Attachment (NCT01966328) | Jeffrey S Heier | 2013-10-01 |
| IReversible Electroporation of Kidney Tumors Before Partial Nephrectomy. (NCT01967407) | University of Magdeburg | 2013-10-01 |
| Reactogenicity, Safety and Immunogenicity of a TB/FLU-04L Tuberculosis Vaccine (NCT02501421) | Research Institute for Biological Safety Problems | 2013-10-01 |
| Dovitinib (TKI258) in the Treatment of Patients With Relapsed Glioblastoma (NCT01972750) | PD Dr. Martin Glas | 2013-10-01 |